Literature DB >> 9324996

Report of a collaborative study to establish the international standard for parvovirus B19 serum IgG.

M Ferguson1, D Walker, B Cohen.   

Abstract

With the introduction of commercial test kits and the wider availability of parvovirus B19 antibody testing, greater standardization is required. Moreover, with a B19 vaccine in the early stages of development, there will be long-term need of accurate measurement of parvovirus B19 antibody levels following natural infection and vaccination. A collaborative study was carried out to assess the suitability of a freeze-dried preparation designated 93/724 to serve as the International Standard for parvovirus B19 serum IgG. The proposed standard, which is a pool of sera from six U.K. blood donors, was assayed along with three coded samples. One was the proposed standard (Preparation A), one a pool of three donor sera (Preparation B) and the third an individual donor serum (Preparation C). These preparations were sent to nine laboratories in seven countries who tested them in 10 different enzyme immunoassays. There were no differences in the antibody content expressed relative to that of the proposed standard in assays using native or recombinant antigen. However, antibody was not detected in serum from an individual blood donor (Preparation C) in assays performed using kits which contained recombinant VP1 but not VP2. This highlights the differences which may be obtained in commercial kits which contain different antigens. The results of this study demonstrated that the proposed standard coded 93/724 is suitable to serve as the International Standard for parvovirus B19 serum IgG and this material has been established as the International Standard for parvovirus B19 IgG by the World Health Organization with an assigned unitage of 100 lU per ampoule. The standard, which is a pool of what can be assumed to be convalescent sera, will be suitable for standardizing diagnostic tests for use in seroprevalence studies and for assessing immunity. An additional standard will be required to standardise tests specifically for the detection of IgM and the diagnosis of acute infection. Copyright 1997 The International Association of Biological Standardization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9324996     DOI: 10.1006/biol.1997.0098

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  7 in total

1.  Impaired gamma interferon responses against parvovirus B19 by recently infected children.

Authors:  A Corcoran; S Doyle; D Waldron; A Nicholson; B P Mahon
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells.

Authors:  Johannes Blümel; Anna Maria Eis-Hübinger; Albert Stühler; Claudia Bönsch; Matthias Gessner; Johannes Löwer
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  High-sensitivity PCR detection of parvovirus B19 in plasma.

Authors:  P Daly; A Corcoran; B P Mahon; S Doyle
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  Is serological testing a reliable tool in laboratory diagnosis of syphilis? Meta-analysis of eight external quality control surveys performed by the german infection serology proficiency testing program.

Authors:  Iris Müller; Volker Brade; Hans-Jochen Hagedorn; Erich Straube; Christoph Schörner; Matthias Frosch; Harald Hlobil; Gerold Stanek; Klaus-Peter Hunfeld
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

5.  Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples.

Authors:  Mei-Ying W Yu; Harvey J Alter; Maria Luisa A Virata-Theimer; Yansheng Geng; Li Ma; Cathy A Schechterly; Camilla A Colvin; Naomi L C Luban
Journal:  Transfusion       Date:  2010-02-12       Impact factor: 3.157

6.  A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion.

Authors:  Steven H Kleinman; Simone A Glynn; Tzong-Hae Lee; Leslie H Tobler; Karen S Schlumpf; Deborah S Todd; Hannah Qiao; Mei-Ying W Yu; Michael P Busch
Journal:  Blood       Date:  2009-08-17       Impact factor: 22.113

7.  Parvovirus B19 diagnosis in pregnant women--quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum.

Authors:  K Searle; C Guilliard; G Enders
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 7.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.